Patents by Inventor Hsin-Ping Chiu

Hsin-Ping Chiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTEGRATED CIRCUIT DEVICE AND MANUFACTURING METHOD THEREOF
    Publication number: 20250056857
    Abstract: An integrated circuit device includes a Janus transition metal dichalcogenide layer, a first gate structure, and a second gate structure. The Janus transition metal dichalcogenide layer has opposite first and second sides. The first gate structure is on the first side of the Janus transition metal dichalcogenide layer. A second gate structure is on the second side of the Janus transition metal dichalcogenide layer.
    Type: Application
    Filed: August 11, 2023
    Publication date: February 13, 2025
    Applicants: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD., NATIONAL TAIWAN UNIVERSITY
    Inventors: Yuh-Renn WU, Yun-Ping CHIU, Hsin-Wen HUANG, Hsiu-Chi PAI
  • Method for inhibiting virus infection and replication
    Patent number: 11679102
    Abstract: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: June 20, 2023
    Assignee: Chang Gung University
    Inventors: Shin-Ru Shih, Yu-An Kung, Huan-Jung Chiang, Chuan-Tien Hung, Yu-Nong Gong, Hsin-Ping Chiu, Chiung-Guei Huang, Peng-Nien Huang, Sheng-Yu Huang
  • METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION
    Publication number: 20210386726
    Abstract: Disclosed herein is a method for inhibiting coronavirus infection, including administering to a subject in need thereof an effective amount of rosiglitazone or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting coronavirus replication, including contacting a coronavirus with rosiglitazone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 16, 2021
    Inventors: Shin-Ru SHIH, Yu-An KUNG, Huan-Jung CHIANG, Chuan-Tien HUNG, Yu-Nong GONG, Hsin-Ping CHIU, Chiung-Guei HUANG, Peng-Nien HUANG, Sheng-Yu HUANG
  • METHOD FOR INHIBITING VIRUS INFECTION AND REPLICATION
    Publication number: 20210386702
    Abstract: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 28, 2021
    Publication date: December 16, 2021
    Inventors: Shin-Ru Shih, Yu-An Kung, Huan-Jung Chiang, Chuan-Tien Hung, Yu-Nong Gong, Hsin-Ping Chiu, Chiung-Guei Huang, Peng-Nien Huang, Sheng-Yu Huang
  • METHOD FOR INHIBITING CORONAVIRUS INFECTION AND REPLICATION
    Publication number: 20210386725
    Abstract: Disclosed herein is a method for inhibiting coronavirus infection, including administering to a subject in need thereof an effective amount of pioglitazone or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting coronavirus replication, including contacting a coronavirus with pioglitazone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 16, 2021
    Inventors: Shin-Ru SHIH, Yu-An KUNG, Huan-Jung CHIANG, Chuan-Tien HUNG, Yu-Nong GONG, Hsin-Ping CHIU, Chiung-Guei HUANG, Peng-Nien HUANG, Sheng-Yu HUANG